BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8111604)

  • 1. Changes in pulmonary function and cross-sectional area of trachea and bronchi in asthmatics following inhalation of procaterol hydrochloride and ipratropium bromide.
    Hoffstein V; Zamel N; McClean P; Chapman KR
    Am J Respir Crit Care Med; 1994 Jan; 149(1):81-5. PubMed ID: 8111604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients.
    Fontana GA; Lavorini F; Chiostri M; Castellani W; Boddi V; Pistolesi M
    J Aerosol Med; 1999; 12(3):177-85. PubMed ID: 10623334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bronchodilatation produced by an anticholinergic (ipratropium bromide), a beta-2 adrenergic (fenoterol) and their combination in patients with chronic obstructive airway disease. An open trial.
    Guleria R; Behera D; Jindal SK
    J Assoc Physicians India; 1991 Sep; 39(9):680-2. PubMed ID: 1839993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cessation of short-term therapy with ipratropium bromide on lung function and airway responsiveness.
    Wilding PJ; Clark MM; Pavord ID; Parker D; Bennett JA; Tattersfield AE
    Eur Respir J; 1996 Aug; 9(8):1627-31. PubMed ID: 8866584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
    Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
    Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ipratropium bromide in bronchial asthma.
    Taskar V; Mirchandani L; Mahashur AA; Sharma RR; Kolhatkar VP
    J Postgrad Med; 1992; 38(3):124-6. PubMed ID: 1303412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
    Thiessen B; Pedersen OF
    Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
    Friberg S; Graff-Lonnevig V
    Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic study of procaterol hydrochloride dry powder inhaler: evaluation of pharmacodynamic equivalence between procaterol hydrochloride dry powder inhaler and procaterol hydrochloride metered-dose inhaler in asthma patients in a randomized, double-dummy, double-blind crossover manner.
    Kawai M; Sakai A; Takaori S; Hiura A; Sakata N; Nakashima M; Miyamoto T
    Methods Find Exp Clin Pharmacol; 2005; 27(6):385-9. PubMed ID: 16179955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of response to inhaled bronchodilators in asthmatics.
    Paré PD; Lawson LM; Brooks LA
    Am Rev Respir Dis; 1983 Jun; 127(6):680-5. PubMed ID: 6222679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis.
    Higgins BG; Powell RM; Cooper S; Tattersfield AE
    Eur Respir J; 1991 Apr; 4(4):415-20. PubMed ID: 1830277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD.
    Sichletidis L; Kottakis J; Marcou S; Constantinidis TC; Antoniades A
    Int J Clin Pract; 1999; 53(3):185-8. PubMed ID: 10665129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response and duration of action assessment of a combined preparation of fenoterol and ipratropium bromide (Duovent).
    Packe GE; Archer PS; Cayton RM
    Postgrad Med J; 1984; 60 Suppl 1():18-22. PubMed ID: 6233546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ipratropium bromide in controlled clinical trials. Short communication (II): Time-response measurements of pulmonary function after ipratropium bromide and isoprenaline].
    Strsemann E
    Arzneimittelforschung; 1976; 26(5a):1015-7. PubMed ID: 134724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilating effect of ipratropium bromide in heart failure.
    Rolla G; Bucca C; Brussino L; Gallo W; Malara D
    Eur Respir J; 1993 Nov; 6(10):1492-5. PubMed ID: 8112444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisolone oral solution plus inhaled procaterol for acute asthma in children: a double-blind randomized controlled trial.
    Huang LH; Shyur SD; Wen DC; Chang YC; Ma YC; Lin SC; Wu WC; Wu JY
    Acta Paediatr Taiwan; 2007; 48(5):257-62. PubMed ID: 18254574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of fenoterol, ipratropium bromide and their combination--Berodual--on pulmonary ventilation in patients with asthma].
    Chyrek-Borowska S; Rutkowski R; Michalska I; Hofman J
    Pol Tyg Lek; 1989 Jul; 44(27):642-5. PubMed ID: 2534666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.